1. Jackson RC (1984) Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol Ther 25: 61–82
2. Allegra CJ (1990) Antifolates. In: BA Chabner, JM Collins (eds): Cancer chemotherapy: principles and practice. JB Lippincott, New York, 110
3. Schultz RM (1995) Newer antifolates in cancer therapy. In: E Jucker (ed): Progress in Drug Research, Vol. 44. Birkhauser Verlag, Basel, 129–157
4. Grindey GB, Shih C, Barnett CJ, Pearce HL, Engelhardt JA, Todd GC, Rinzel SM, Worzalla JF, Gossett LS, Everson TP et al (1992) LY231514, a novel pyrrolopyrimidine antifolate that inhibits thymidylate synthase (TS). Proc Am Assoc Cancer Res 33: 411
5. Taylor EC, Kuhnt D, Shih C, Rinzel SM, Grindey GB, Barredo J, Jannatipour M, Moran RG (1992) A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydryo-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]-benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase. J Med Chem 35: 4450–4454